Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021. He will be a fellow of Merton College. A donation from the WA Handley Trust endowed the first Chair of Psychiatry in the University of Oxford’s Department of Psychiatry, which was founded in 1969.

John Geddes
It’s a true honour to be appointed to a statutory chair at Oxford University. Even in normal times Oxford is an astonishing place and I am simply awestruck by what this place has done in the battle against the virus. The WA Handley Chair will help me ensure that we learn from this to bring the same urgency, widespread collaboration and intellectual inspiration to bear on mental health. - Professor John Geddes, Head of Department of Psychiatry

The Department of Psychiatry and Merton College, one of the oldest colleges in Oxford with a strong commitment to excellence in research and teaching, held a rigorous search and selection process for this prestigious clinical academic post. The position provides an unparalleled opportunity to develop and sustain a large scale research programme, supported by the world-leading clinical research infrastructure in Oxford.

Mental health research is a priority for the University of Oxford, which is working closely with Oxford Health NHS Foundation Trust through the NIHR Oxford Health Biomedical Research Centre.

Previous post holders include the late Professor Michael Gelder, the founder of the Department of Psychiatry at the University of Oxford, and Professor Guy Goodwin.

Read the full story on the Department of Psychiatry website

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.